<?xml version="1.0"?>
<!--<!DOCTYPE nitf SYSTEM "nitf-3-4.dtd">-->
<nitf>
  <head>
    <title id="Title"></title>
    <docdata management-doc-idref="">
      <date.issue id="CreationDate" norm="" />
      <du-key id="rev-ver" generation="1" version="Default" />
      <du-key id="Parent-Version" version="" />
      <identified-content>
        <classifier id="newspro-nitf" value="r2" />
        <classifier id="Newspro-App" value="Epaper" />
        <classifier id="Content-Type" value="Story" />
        <classifier id="storyID" value="408346" />
        <classifier id="CmsConID" value="" />
        <classifier id="Desk" value="" />
        <classifier id="Source" value="" />
        <classifier id="Edition" value="" />
        <classifier id="Category" value="-1" />
        <classifier id="UserName" value="" />
        <classifier id="PublicationDate" value="30/05/2026" />
        <classifier id="PublicationName" value="DailyStar" />
        <classifier id="IsPublished" value="Y" />
        <classifier id="IsPlaced" value="Y" />
        <classifier id="IsCompleated" value="N" />
        <classifier id="IsProofed" value="N" />
        <classifier id="User" value="" />
        <classifier id="Headline-Count" value="" />
        <classifier id="Slug-Count" value="0" />
        <classifier id="Photo-Count" value="0" />
        <classifier id="Caption-Count" value="0" />
        <classifier id="Word-Count" value="0" />
        <classifier id="Character-Count" value="0" />
        <classifier id="Location" value="" />
        <classifier id="TemplateType" value="1" />
        <classifier id="StoryType" value="Story" />
        <classifier id="Author" value="" />
        <classifier id="UOM" value="mm" />
        <classifier id="kicker" value="" />
        <classifier id="ByLine" value="" />
        <classifier id="DateLine" value="" />
        <classifier id="box-geometry" value="775,114,972,453" />
         <classifier id="numcol" value="1"/>
      <classifier id="ArticleStyle" value=""/>
      <classifier id="Layer" value="Layer 1"/>
         <classifier id="Epaper-Build" value="7.1.5.2"/>
  <classifier id="ProcessingDateTime" value="Sat May 30 2026 00:16:12 GMT+0600"/>
      </identified-content>

      <urgency id="home-page" ed-urg="0" />
      <urgency id="priority" ed-urg="0" />
      <doc-scope id="scope" value="0" />
    </docdata>
    <pubdata type="print" name="DailyStar" date.publication="20260530T000000+5.30" edition.name="Dhaka Edition" edition.area="MAI" position.section="DST30052602MAI-NEWS" position.sequence="2" ex-ref="DST30052602MAI-NEWS.indd" />
  </head>
  <body boxBorderWeightColor="" boxBorderWeight="">
<body.head>
      <hedline>
    	<hl1 id="Headline1" ul="0" ol="0" ulColor=""  ulWeight=""  olColor=""  olWeight="" textFrameColor="" orgstyle="SHOULDER 1C new" class="1" MainHead="true" style="Headline1">
		<lang class="3" colour="#000000" orgstyle="SHOULDER 1C new" style="Headline1"  font="Blacker Pro Display" fontStyle="Bold" size="13">EBOLA OUTBREAK WHO CONFIRMS FIRST RECOVERY IN DRC </lang>
	</hl1>
<hl2 id="Headline1" ul="0" ol="0" ulColor=""  ulWeight=""  olColor=""  olWeight="" textFrameColor="" orgstyle="2ND HEAD 1C new" class="1" MainHead="false" style="Headline2">
		<lang class="3" colour="#000000" orgstyle="2ND HEAD 1C new" style="Headline2"  font="Blacker Pro Display" fontStyle="Bold" size="13">Identifies treatments; vaccines  to be tested in trials </lang>
	</hl2>

       </hedline>
</body.head>
    <body.content id="Bodytext" CaptionAsBody="0">
     <block>
	<media id="1" media-type="image">
			</media>
</block>

     <p style=".Bodylaser" ul="1" ol="0"  orgstyle="BY NAME LINE new">
	<lang class="3" style=".Bodylaser" colour="#000000" orgstyle="BY NAME LINE new" font="Blacker Pro Display" fontStyle="Bold" size="8">AGENCIES
</lang>
</p>
<p style=".Bodylaser" ul="0" ol="0"  orgstyle="INDENTLESS BODY new">
	<lang class="3" style=".Bodylaser" colour="#000000" orgstyle="INDENTLESS BODY new" font="Blacker Pro Display" fontStyle="Regular" size="9">The World Health Organization (WHO) yesterday announced the first recovery of a confirmed Ebola patient in the outbreak raging in the Democratic Republic of Congo.
</lang>
</p>
<p style=".Bodylaser" ul="0" ol="0"  orgstyle="BODY new">
	<lang class="3" style=".Bodylaser" colour="#000000" orgstyle="BODY new" font="Blacker Pro Display" fontStyle="Regular" size="9">“The DRC has said that on May 27, a patient recovered and left the hospital and has been discharged into the community,” the WHO’s Anais Legand told reporters, adding it was “the first one”.
</lang>
</p>
<p style=".Bodylaser" ul="0" ol="0"  orgstyle="BODY new">
	<lang class="3" style=".Bodylaser" colour="#000000" orgstyle="BODY new" font="Blacker Pro Display" fontStyle="Regular" size="9">WHO said there are 906 suspected cases of Ebola in the Democratic Republic of Congo, including 223 suspected deaths that are being investigated.
</lang>
</p>
<p style=".Bodylaser" ul="0" ol="0"  orgstyle="BODY new">
	<lang class="3" style=".Bodylaser" colour="#000000" orgstyle="BODY new" font="Blacker Pro Display" fontStyle="Regular" size="9">There have been 125 confirmed cases of Ebola in the DRC, including 17 confirmed deaths in Ituri, North Kivu and South Kivu. 
</lang>
</p>
<p style=".Bodylaser" ul="0" ol="0"  orgstyle="BODY new">
	<lang class="3" style=".Bodylaser" colour="#000000" orgstyle="BODY new" font="Blacker Pro Display" fontStyle="Regular" size="9">There have also been seven confirmed cases of Ebola in Uganda, three of which were imported from the DRC, and one death. However, no community transmission has been reported, the WHO said.
</lang>
</p>
<p style=".Bodylaser" ul="0" ol="0"  orgstyle="BODY new">
	<lang class="3" style=".Bodylaser" colour="#000000" orgstyle="BODY new" font="Blacker Pro Display" fontStyle="Regular" size="9">Meanwhile, WHO recommended prioritising three experimental treatments for the Bundibugyo strain of Ebola, including Mapp Biopharmaceutical’s MBP134, Regeneron’s maftivimab, and Gilead Sciences’ antiviral remdesivir.
</lang>
</p>

    </body.content>
  </body>
</nitf>